U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07152613) titled 'Adaptive RCT of Corticosteroids for PJP in Non-HIV Immunocompromised Adults' on Aug. 26.
Brief Summary: Pneumocystis jirovecii pneumonia (PJP) is one of the common severe complications in immunocompromised patients, with a reported mortality rate of 60-80%. Reducing mortality from PJP is crucial for improving outcomes in critically ill non-HIV immunocompromised patients and alleviating the burden on families and society. To address this medical challenge, our institution is conducting a study aimed at lowering PJP-related mortality. Specifically, we are performing an adaptive, randomized, open-label controlled trial in patients with...